By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer On March 24, 2025, Imunon, Inc. (NASDAQ:IMNN) announced it reached alignment with the U.S. FDA on the protocol for a Phase 3 clinical trial, referred to as OVATION 3, of … Read more
By Brian Lantier, CFA NASDAQ:VIOT READ THE FULL VIOT RESEARCH REPORT On Tuesday, March 25th, Viomi Technology (NASDAQ:VIOT) released its second half and full year for 2024. As a result of the company’s divestiture of its IoT business in August 2024, the company is a pure-play home water systems and home appliance company. Importantly, the … Read more
By M. Marin NASDAQ:GMGI READ THE FULL GMGI RESEARCH REPORT STRONG 2024 GROWTH; MOMENTUM EXPECTED TO CONTINUE IN 2025/BEYOND Revenue growth across all business lines Golden Matrix Group (NASDAQ:GMGI), an iGaming group providing a broad array of gaming products and software solutions on a B2B and B2C basis, reported 4Q24/2024 results this week, turning in … Read more
By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that the company can move forward with upgrades and begin the commercialization process. The mBôs TKA System is designed to deliver … Read more
By John Vandermosten, CFA NASDAQ:MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ:MDAI) reported topline data from its burn validation study in a March 17th press release confirming DeepView’s superior detection sensitivity relative to burn physicians. The announcement reminded stakeholders of the device’s background and development along with a description of the burn study’s … Read more